Lipopolysaccharide binding protein-deficient mice have a normal defense against pulmonary mycobacterial infection

Clinical Immunology

Volumn 116, Issue 2, 2005, Pages 174-181

  Branger, Judith ^a   Leemans, Jaklien C ^a   Florquin, Sandrine ^a   Speelman, Peter ^a   Golenbock, Douglas T ^b   Van Der Poll, Tom ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

Inflammation; Innate host defense; Lipopolysaccharide binding protein; Murine model; Tuberculosis

Indexed keywords

LIPOPOLYSACCHARIDE BINDING PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL GROWTH; BACTERIAL IMMUNITY; CLEARANCE; CONTROLLED STUDY; DISEASE COURSE; EXPERIMENTAL INFECTION; HOST RESISTANCE; IMMUNE RESPONSE; KNOCKOUT MOUSE; LIVER; LUNG; LUNG TUBERCULOSIS; LYMPHOCYTE ACTIVATION; LYMPHOCYTE FUNCTION; MOUSE; MYCOBACTERIOSIS; MYCOBACTERIUM SMEGMATIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN FUNCTION; SURVIVAL; WILD TYPE;

ACUTE-PHASE PROTEINS; ANIMALS; CARRIER PROTEINS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL COUNT; CHEMOKINES; CYTOKINES; FEMALE; GRANULOCYTES; LIVER; LUNG; LYMPHOCYTE ACTIVATION; LYMPHOCYTES; MACROPHAGES; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MYCOBACTERIUM INFECTIONS, ATYPICAL; MYCOBACTERIUM SMEGMATIS; SURVIVAL ANALYSIS; TUBERCULOSIS, PULMONARY;

EID: 21444461394     PISSN: 15216616     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clim.2005.03.014     Document Type: Article

References (55)

1. R.J. Ulevitch, and P.S. Tobias Recognition of Gram-negative bacteria and endotoxin by the innate immune system Curr. Opin. Immunol. 11 1999 19 22
2. S.D. Wright, R.A. Ramos, P.S. Tobias, R.J. Ulevitch, and J.C. Mathison CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein Science 249 1990 1431 1433
3. A. Aderem, and R.J. Ulevitch Toll-like receptors in the induction of the innate immune response Nature 406 2000 782 787
4. K. Hoshino, O. Takeuchi, T. Kawai, H. Sanjo, T. Ogawa, Y. Takeda, K. Takeda, and S. Akira Cutting edge: toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product J. Immunol. 162 1999 3749 3752
5. R. Shimazu, S. Akashi, H. Ogata, Y. Nagai, K. Fukudome, K. Miyake, and M. Kimoto MD-2, a molecule that confers lipopolysaccharide responsiveness on Toll-like receptor 4 J. Exp. Med. 189 1999 1777 1782
6. P. Gallay, D. Heumann, D. Le Roy, C. Barras, and M.P. Glauser Lipopolysaccharide-binding protein as a major plasma protein responsible for endotoxemic shock Proc. Natl. Acad. Sci. U. S. A. 90 1993 9935 9938
7. P. Gallay, D. Heumann, D. Le Roy, C. Barras, and M.P. Glauser Mode of action of anti-lipopolysaccharide-binding protein antibodies for prevention of endotoxemic shock in mice Proc. Natl. Acad. Sci. U. S. A. 91 1994 7922 7926
8. D. Le Roy, F. Di Padova, R. Tees, S. Lengacher, R. Landmann, M.P. Glauser, T. Calandra, and D. Heumann Monoclonal antibodies to murine lipopolysaccharide (LPS)-binding protein (LBP) protect mice from lethal endotoxemia by blocking either the binding of LPS to LBP or the presentation of LPS/LBP complexes to CD14 J. Immunol. 162 1999 7454 7460
9. M.M. Wurfel, B.G. Monks, R.R. Ingalls, R.L. Dedrick, R. Delude, D. Zhou, N. Lamping, R.R. Schumann, R. Thieringer, M.J. Fenton, S.D. Wright, and D. Golenbock Targeted deletion of the lipopolysaccharide (LPS)-binding protein gene leads to profound suppression of LPS responses ex vivo, whereas in vivo responses remain intact J. Exp. Med. 186 1997 2051 2056
10. R.S. Jack, X. Fan, M. Bernheiden, G. Rune, M. Ehlers, A. Weber, G. Kirsch, R. Mentel, B. Furll, M. Freudenberg, G. Schmitz, F. Stelter, and C. Schutt Lipopolysaccharide-binding protein is required to combat a murine Gram-negative bacterial infection Nature 389 1997 742 745
11. M. Bernheiden, J.M. Heinrich, G. Minigo, C. Schutt, F. Stelter, M. Freeman, D. Golenbock, and R.S. Jack LBP, CD14, TLR4 and the murine innate immune response to a peritoneal Salmonella infection J. Endotoxin. Res. 7 2001 447 450
12. J.M. Heinrich, M. Bernheiden, G. Minigo, K.K. Yang, C. Schutt, D.N. Mannel, and R.S. Jack The essential role of lipopolysaccharide-binding protein in protection of mice against a peritoneal Salmonella infection involves the rapid induction of an inflammatory response J. Immunol. 167 2001 1624 1628
13. J. Fierer, M.A. Swancutt, D. Heumann, and D. Golenbock The role of lipopolysaccharide binding protein in resistance to Salmonella infections in mice J. Immunol. 168 2002 6396 6403
14. D. Le Roy, F. Di Padova, Y. Adachi, M.P. Glauser, T. Calandra, and D. Heumann Critical role of lipopolysaccharide-binding protein and CD14 in immune responses against Gram-negative bacteria J. Immunol. 167 2001 2759 2765
15. M.H. Fan, R.D. Klein, L. Steinstraesser, A.C. Merry, J.A. Nemzek, D.G. Remick, S.C. Wang, and G.L. Su An essential role for lipopolysaccharide-binding protein in pulmonary innate immune responses Shock 18 2002 248 254
16. S. Knapp, A.F. de Vos, S. Florquin, D.T. Golenbock, and T. van der Poll Lipopolysaccharide binding protein is an essential component of the innate immune response to Escherichia coli peritonitis in mice Infect. Immun. 71 2003 6747 6753
17. C. Dye, S. Scheele, P. Dolin, V. Pathania, and M.C. Raviglione Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project JAMA 282 1999 677 686
18. World Health Organisation The World Health Report 2000. Health Systems: Improving Performance 2000 WHO Geneva, Switserland
19. J.L. Flynn, and J. Chan Immunology of tuberculosis Annu. Rev. Immunol. 19 2001 93 129
20. R. Savedra Jr., R.L. Delude, R.R. Ingalls, M.J. Fenton, and D.T. Golenbock Mycobacterial lipoarabinomannan recognition requires a receptor that shares components of the endotoxin signaling system J. Immunol. 157 1996 2549 2554
21. D. Chatterjee, K. Lowell, B. Rivoire, M.R. McNeil, and P.J. Brennan Lipoarabinomannan of Mycobacterium tuberculosis. Capping with mannosyl residues in some strains J. Biol. Chem. 267 1992 6234 6239
22. K.H. Khoo, A. Dell, H.R. Morris, P.J. Brennan, and D. Chatterjee Inositol phosphate capping of the nonreducing termini of lipoarabinomannan from rapidly growing strains of Mycobacterium J. Biol. Chem. 270 1995 12380 12389
23. T.I. Roach, C.H. Barton, D. Chatterjee, and J.M. Blackwell Macrophage activation: lipoarabinomannan from avirulent and virulent strains of Mycobacterium tuberculosis differentially induces the early genes c-fos, KC, JE, and tumor necrosis factor-alpha J. Immunol. 150 1993 1886 1896
24. D. Chatterjee, A.D. Roberts, K. Lowell, P.J. Brennan, and I.M. Orme Structural basis of capacity of lipoarabinomannan to induce secretion of tumor necrosis factor Infect. Immun. 60 1992 1249 1253
25. J. Bernardo, A.M. Billingslea, R.L. Blumenthal, K.F. Seetoo, E.R. Simons, and M.J. Fenton Differential responses of human mononuclear phagocytes to mycobacterial lipoarabinomannans: role of CD14 and the mannose receptor Infect. Immun. 66 1998 28 35
26. N.P. Juffermans, A. Verbon, J.T. Belisle, P.J. Hill, P. Speelman, S.J. van Deventer, and T. van der Poll Mycobacterial lipoarabinomannan induces an inflammatory response in the mouse lung. A role for interleukin-1 Am. J. Respir. Crit. Care Med. 162 2000 486 489
27. N.P. Juffermans, A. Verbon, S.J.H. van Deventer, H. van Deutekom, J.T. Belisle, M.E. Ellis, P. Speelman, and T. van der Poll Elevated chemokine concentrations in sera of human immunodeficiency virus (HIV)-seropositive and HIV-seronegative patients with tuberculosis: a possible role for mycobacterial lipoarabinomannan Infect. Immun. 67 1999 4295 4297
28. N.P. Juffermans, W.A. Paxton, P.E. Dekkers, A. Verbon, E. de Jonge, P. Speelman, S.J. van Deventer, and T. van der Poll Up-regulation of HIV coreceptors CXCR4 and CCR5 on CD4(+) T cells during human endotoxemia and after stimulation with (myco)bacterial antigens: the role of cytokines Blood 96 2000 2649 2654
29. N.P. Juffermans, P.E. Dekkers, A. Verbon, P. Speelman, S.J. van Deventer, and T. van der Poll Concurrent upregulation of urokinase plasminogen activator receptor and CD11b during tuberculosis and experimental endotoxemia Infect. Immun. 69 2001 5182 5185
30. T.K. Means, E. Lien, A. Yoshimura, S. Wang, D.T. Golenbock, and M.J. Fenton The CD14 ligands lipoarabinomannan and lipopolysaccharide differ in their requirement for toll-like receptors J. Immunol. 163 1999 6748 6755
31. T.K. Means, S. Wang, E. Lien, A. Yoshimura, D.T. Golenbock, and M.J. Fenton Human toll-like receptors mediate cellular activation by Mycobacterium tuberculosis J. Immunol. 163 1999 3920 3927
32. T.K. Means, B.W. Jones, A.B. Schromm, B.A. Shurtleff, J.A. Smith, J. Keane, D.T. Golenbock, S.N. Vogel, and M.J. Fenton Differential effects of a Toll-like receptor antagonist on Mycobacterium tuberculosis-induced macrophage responses J. Immunol. 166 2001 4074 4082
33. D.M. Underhill, A. Ozinsky, K.D. Smith, and A. Aderem Toll-like receptor-2 mediates mycobacteria-induced proinflammatory signaling in macrophages Proc. Natl. Acad. Sci. 96 1999 14459 14463
34. M.C. Brown, and S.M. Taffet Lipoarabinomannans derived from different strains of Mycobacterium tuberculosis differentially stimulate the activation of NF-kappa B and KBF1 in murine macrophages Infect. Immun. 63 1995 1960 1968
35. Y. Zhang, M. Doerfler, T.C. Lee, B. Guillemin, and W.N. Rom Mechanisms of stimulation of interleukin-1 beta and tumor necrosis factor-alpha by Mycobacterium tuberculosis components J. Clin. Invest. 91 1993 2076 2083
36. M.A. Dentener, A.C. Vreugdenhil, P.H. Hoet, J.H. Vernooy, F.H. Nieman, D. Heumann, Y.M. Janssen, W.A. Buurman, and E.F. Wouters Production of the acute-phase protein lipopolysaccharide-binding protein by respiratory type II epithelial cells: implications for local defense to bacterial endotoxins Am. J. Respir. Cell Mol. Biol. 23 2000 146 153
37. T.R. Martin, G.D. Rubenfeld, J.T. Ruzinski, R.B. Goodman, K.P. Steinberg, D.J. Leturcq, A.M. Moriarty, G. Raghu, R.P. Baughman, and L.D. Hudson Relationship between soluble CD14, lipopolysaccharide binding protein, and the alveolar inflammatory response in patients with acute respiratory distress syndrome Am. J. Respir. Crit. Care Med. 155 1997 937 944
38. W. Dubin, T.R. Martin, P. Swoveland, D.J. Leturcq, A.M. Moriarty, P.S. Tobias, E.R. Bleecker, S.E. Goldblum, and J.D. Hasday Asthma and endotoxin: lipopolysaccharide-binding protein and soluble CD14 in bronchoalveolar compartment Am. J. Physiol. 270 1996 L736 L744
39. N.P. Juffermans, A. Verbon, S.J. van Deventer, W.A. Buurman, H. van Deutekom, P. Speelman, and T. van der Poll Serum concentrations of lipopolysaccharide activity-modulating proteins during tuberculosis J. Infect. Dis. 178 1998 1839 1842
40. J.C. Leemans, N.P. Juffermans, S. Florquin, N. van Rooijen, M.J. Vervoordeldonk, A. Verbon, S.J. van Deventer, and T. van der Poll Depletion of alveolar macrophages exerts protective effects in pulmonary tuberculosis in mice J. Immunol. 166 2001 4604 4611
41. J.C. Leemans, S. Florquin, M. Heikens, S.T. Pals, R.v.d. Neut, and T. van der Poll CD44 is a macrophage binding site for Mycobacterium tuberculosis that mediates macrophage recruitment and protective immunity against tuberculosis J. Clin. Invest. 111 2003 681 689
42. N.P. Juffermans, J.C. Leemans, S. Florquin, A. Verbon, A.H. Kolk, P. Speelman, S.J. van Deventer, and T. van der Poll CpG oligodeoxynucleotides enhance host defense during murine tuberculosis Infect. Immun. 70 2002 147 152
43. K.J. Erb, J.W. Holloway, A. Sobeck, H. Moll, and G. Le Gros Infection of mice with Mycobacterium bovis-Bacillus Calmette-Guerin (BCG) suppresses allergen-induced airway eosinophilia J. Exp. Med. 187 1998 561 569
44. B.M. Saunders, and C. Cheers Intranasal infection of beige mice with Mycobacterium avium complex: role of neutrophils and natural killer cells Infect. Immun. 64 1996 4236 4241
45. N.P. Juffermans, S. Florquin, L. Camoglio, A. Verbon, A.H. Kolk, P. Speelman, S.J. van Deventer, and T. van Der Poll Interleukin-1 signaling is essential for host defense during murine pulmonary tuberculosis J. Infect. Dis. 182 2000 902 908
46. A.M. Cooper, and J.L. Flynn The protective immune response to Mycobacterium tuberculosis Curr. Opin. Immunol. 7 1995 512 516
47. P. Andersen Host responses and antigens involved in protective immunity to Mycobacterium tuberculosis Scand. J. Immunol. 45 1997 115 131
48. A.M. Caruso, N. Serbina, E. Klein, K. Triebold, B.R. Bloom, and J.L. Flynn Mice deficient in CD4 T cells have only transiently diminished levels of IFN-gamma, yet succumb to tuberculosis J. Immunol. 162 1999 5407 5416
49. T.R. Martin Recognition of bacterial endotoxin in the lungs Am. J. Respir. Cell Mol. Biol. 23 2000 128 132
50. J. Faldt, C. Dahlgren, and M. Ridell Difference in neutrophil cytokine production induced by pathogenic and non-pathogenic mycobacteria APMIS 110 2002 593 600
51. S. Stenger, and R.L. Modlin Control of Mycobacterium tuberculosis through mammalian Toll-like receptors Curr. Opin. Immunol. 14 2002 452 457
52. B. Abel, N. Thieblemont, V.J. Quesniaux, N. Brown, J. Mpagi, K. Miyake, F. Bihl, and B. Ryffel Toll-like receptor 4 expression is required to control chronic Mycobacterium tuberculosis infection in mice J. Immunol. 169 2002 3155 3162
53. N. Reiling, C. Holscher, A. Fehrenbach, S. Kroger, C.J. Kirschning, S. Goyert, and S. Ehlers Cutting edge: toll-like receptor (TLR)2- and TLR4-mediated pathogen recognition in resistance to airborne infection with Mycobacterium tuberculosis J. Immunol. 169 2002 3480 3484
54. A.B. Kamath, J. Alt, H. Debbabi, and S.M. Behar Toll-like receptor 4-defective C3H/HeJ mice are not more susceptible than other C3H substrains to infection with Mycobacterium tuberculosis Infect. Immun. 71 2003 4112 4118
55. I. Sugawara, H. Yamada, C. Li, S. Mizuno, O. Takeuchi, and S. Akira Mycobacterial infection in TLR2 and TLR6 knockout mice Microbiol. Immunol. 47 2003 327 336